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Abstract
Background: Most quality improvement programs in diabetes care incorporate aspects of
clinician education, performance feedback, patient education, care management, and diabetes care
teams to support primary care physicians. Few studies have applied all of these dimensions to
address clinical inertia.
Aim: To evaluate interventions to improve adherence to evidence-based guidelines for diabetes
and reduce clinical inertia in primary care physicians.
Design: Two-arm cluster randomized controlled trial.
Participants: Primary care physicians in Belgium.
Interventions: Primary care physicians will be randomly allocated to 'Usual' (UQIP) or 'Advanced'
(AQIP) Quality Improvement Programs. Physicians in the UQIP will receive interventions
addressing the main physician, patient, and office system factors that contribute to clinical inertia.
Physicians in the AQIP will receive additional interventions that focus on sustainable behavior
changes in patients and providers.
Outcomes: Primary endpoints are the proportions of patients within targets for three clinical
outcomes: 1) glycosylated hemoglobin < 7%; 2) systolic blood pressure differences ≤130 mmHg;
and 3) low density lipoprotein/cholesterol < 100 mg/dl. Secondary endpoints are individual
improvements in 12 validated parameters: glycosylated hemoglobin, low and high density
lipoprotein/cholesterol, total cholesterol, systolic blood pressure, diastolic blood pressure, weight,
physical exercise, healthy diet, smoking status, and statin and anti-platelet therapy.
Published: 6 October 2008
Implementation Science 2008, 3:42 doi:10.1186/1748-5908-3-42
Received: 30 June 2008
Accepted: 6 October 2008
This article is available from: http://www.implementationscience.com/content/3/1/42
© 2008 Borgermans et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Implementation Science 2008, 3:42 http://www.implementationscience.com/content/3/1/42
Page 2 of 11
(page number not for citation purposes)
Primary and secondary analysis: Statistical analyses will be performed using an intent-to-treat
approach with a multilevel model. Linear and generalized linear mixed models will be used to
account for the clustered nature of the data, i.e., patients clustered withinimary care physicians, and
repeated assessments clustered within patients. To compare patient characteristics at baseline and
between the intervention arms, the generalized estimating equations (GEE) approach will be used,
taking the clustered nature of the data within physicians into account. We will also use the GEE
approach to test for differences in evolution of the primary and secondary endpoints for all
patients, and for patients in the two interventions arms, accounting for within-patient clustering.
Trial Registration: number: NTR 1369.
Background
Diabetes management is a complex process requiring
physiological, psychological, and social interventions
[1,2]. Although considerable evidence supports the use of
pharmacological interventions in diabetes care [3,4], the
best way to improve health outcomes using non-pharma-
cological 'complex interventions' is often unclear [5]. A
number of complex interventions target improvements in
patient, provider, and organizational aspects of diabetes
care [6]. The active components of these complex inter-
ventions are essential to their proper functioning and may
act both independently and interdependently [7]. The
Chronic Care Model (CCM) is often used as a conceptual
framework to underpin complex interventions in diabetes
care [8,9]. According to this model, patient outcomes such
as good control of risk factors are associated with the pres-
ence of one or more interrelated components: community
resources, self-management support, delivery system rede-
sign, decision support, clinical information systems, and
organizational support [8]. Most quality improvement
programs in diabetes care cover several dimensions of the
CCM, in particular those supported by substantial evi-
dence of improved outcomes of care in selected popula-
tions [10]. Clinician education and dissemination of
guidelines [11,12], feedback on performance [13], patient
education [14,15], care management [16,17], and diabe-
tes care teams (DCTs) to support primary care physicians
[18-20] represent examples of such interventions. Few
studies have applied all dimensions of the CCM to
address non-adherence to evidence-based guidelines and
to reduce 'clinical inertia' in primary care physicians [21-
23].
Clinical inertia is defined as a lack of treatment initiation
or intensification in a patient that is not achieving evi-
dence-based goals of care [24]; this is consistent with the
definition of medical errors given by the Institute of Med-
icine [25,26]. Clinical inertia increases the likelihood of
adverse outcomes in a high proportion of patients, but it
may take years for poorer clinical outcomes to become
apparent [27]. Numerous authors, including those who
report on clinical inertia, have defined three principal
sources for non-adherence to evidence-based guidelines
and clinical inertia: physician factors, patient factors, and
office system and organizational factors [28-30]. Physi-
cian factors that contribute to clinical inertia include an
overestimation of care actually delivered, a failure to iden-
tify and manage comorbid conditions, disagreement with
evidence-based goals of care and the use of 'soft reasons'
to avoid intensification of therapy (e.g., patient refusal)
[31,32]. Patient factors that contribute to clinical inertia
are limited motivation or resistance to adopting lifestyles
that support optimal disease care, which stresses the
importance of patient empowerment as a cornerstone to
high-quality diabetes care [33,34]. Office system and
organizational factors that contribute to clinical inertia
are the absence of decision support and a team approach
to care. These three sources interact in complex ways, and
interventions to reduce clinical inertia therefore need to
be multifactorial in nature. Here, we describe a study pro-
tocol of a cluster randomized trial. We have chosen the
physician's practice as the unit of randomization since
this was considered the most feasible method of conduct-
ing the trial. We plan to compare two different interven-
tions for improving adherence to evidence based
guidelines and reducing clinical inertia in primary care
physicians.
Aim of the study
Our program goal is to improve adherence to evidence-
based guidelines and to reduce clinical inertia in primary
care physicians, and to therefore improve the manage-
ment of glycemic control and cardio-vascular risk factors
in persons with diabetes.
Scientific hypothesis
One hypothesis is that an advanced quality improvement
program (AQIP) significantly improves clinical outcomes
in persons with type 2 diabetes compared to a usual qual-
ity improvement program (UQIP). Subgroup analyses can
analyze the effect of the program in the two intervention
arms using cut-off values. The second hypothesis is that
persons with type 2 diabetes who make use of a DCT will
have significantly better outcomes compared to non-users
of the DCT, regardless of their intervention arm.
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Methods
Study design
The study is an open pragmatic cluster randomized trial
with before/after measurements and two intervention
arms. A cluster design is necessary because randomization
is performed on a practice level, the intervention happens
on the physician level, but a large part of the data are ana-
lyzed at the patient level. The implementation period of
the trial is 18 months.
Participants
All 379 active primary care physicians (PCPs) in the
project region are invited to participate in the project.
These PCPs work in a semi-rural setting with 357,000
inhabitants and serve predominantly Caucasian patients
with type 2 diabetes mellitus. PCPs provide care for
approximately 80% of patients with type 2 diabetes, and
are often the sole providers of care. The only inclusion cri-
terion for the providers is agreeing to recruit all patients
with type 2 diabetes mellitus to prevent selection bias. In
addition, PCPs will be asked to screen more systematically
for new type 2 diabetes mellitus patients during the seven
months after registration begins. Diabetes is defined in
accordance with the 2003 ADA criteria [35] with PCPs
making the final diagnosis.
Only patients with type 2 diabetes mellitus will be
included in the study, regardless of age. Patients who can-
not provide informed consent will be excluded from the
study.
Intervention
The UK Medical Research Council (MRC) framework for
the development and evaluation of complex interventions
for randomized control trials (RCT) is used as a theoreti-
cal guide to designing the intervention [6]. The MRC
framework allows for the development of a high-quality
study design, execution, generalizability of the results, and
outlines five key phases for intervention development: a
preclinical/theoretical phase, a modeling phase, a phase
of exploratory trials prior to the randomized controlled
trial (RCT), the trial itself, and long-term implementation
[36]. All phases except phase two (exploratory trial phase)
and phase five (long-term implementation phase) are
incorporated here. A detailed overview is provided in
Table 1.
Preclinical phase of the MRC framework
This phase involves exploration of the relevant theory and
evidence to refine the underlying hypotheses, conceptual
model, interventions, and indicators. We have previously
performed a review of systematic reviews for this purpose
[37]. A total of 21 systematic reviews (1989–2006) were
included in the review and represented 185 diabetes care
programs. Conceptual background, goals, settings, type of
programs, type and number of interventions, type and
number of indicators, and (cost) effectiveness were evalu-
ated in both the 21 systematic reviews and the individual
diabetes care programs. The program is further built on
the CCM [8,9] and principles of integrated care. As there
is no unambiguous definition of integrated care, we fur-
ther build on the definitions of Ellrodt and colleagues
[38], Mur-Veeman and colleagues [39], and the Disease
Management Association of America (DMAA) [40]. We
consider integrated care as 'an organizational process of
continuous coordination of evidence-based and relevant
interventions across the entire health care delivery system
and care continuum that seeks to maximize quality of care
tailored to the needs of every individual patient while
minimizing costs'.
Besides exploring relevant theory and evidence, the local
context in terms of existing national and regional govern-
mental policies, characteristics of the region, and per-
ceived barriers to high-quality diabetes care were
extensively studied with regard to their impact on the con-
tent and execution of the study protocol. We have previ-
ously organized stakeholder interviews, including a
representative group of 18 Belgian opinion leaders and
experts in diabetes care [41].
Modeling phase
In the modeling phase, we delineated the components of
our complex intervention and the underlying mecha-
nisms by which they influence the outcomes. We sought
to understand the pathways by which the problem is
caused and sustained, including all barriers to high-qual-
ity diabetes care. We also explored whether the pathways
were amenable to change, and if so, at which points.
Finally, we estimated potential for improvement in both
process and primary outcomes. This analysis produced
the best achievable combination of intervention compo-
nents, implementation strategies, and intensities of care
delivery, as well as the identification of feasible and valid
outcome measures.
Interventions
Two separate groups are defined: the first group will
receive a usual quality improvement program (UQIP),
and a second group will receive an advanced quality
improvement program (AQIP). Physicians can make use
of program services on a voluntary basis.
The UQIP arm will aim to improve adherence to evidence-
based guidelines and to reduce the rate of clinical inertia
in PCPs. The term 'usual' is applied because these inter-
ventions address the principal factors contributing to clin-
ical inertia (physician, patient, and office system factors)
and represent standard requirements for what is consid-
ered quality of diabetes care in most health care systems
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according to international clinical guidelines [42], and
theoretical frameworks on quality of diabetes care in par-
ticular [43]. The first intervention arm is innovative to the
Belgian healthcare system and adds to available insights
from the international literature on how to address clini-
cal inertia in diabetes care.
The AQIP arm will receive similar interventions, but will
also include supplementary and experimental interven-
tions that extensively focus on behavior changes in
patients and providers. Interventions that focus on the
patient aim at a more active involvement of the patient in
his/her treatment regimen, with a special focus on lifestyle
attitude changes. Improvements in 'patient empower-
ment' will further decrease clinical inertia by increasing
the patient's willingness to intensify his/her treatment
[44,45]. Interventions that target the PCP focus on
improvements in communication patterns with patients,
interdisciplinary shared care, and involving PCPs in com-
munity campaigns. This multi-factorial approach, with a
focus on patient, provider, and organizational aspects of
care, is fully in line with the latest insights and findings on
high-quality chronic care, and high-quality diabetes care
in particular [9,19,46-53].
The differences between the AQIP and the UQIP are out-
lined further below and in Table 2.
We will use two classification schemes to incorporate all
six dimensions of the CCM based on the classification
scheme from Shojania and colleagues [54], who defined
eleven distinct categories of quality improvement inter-
ventions adapted from the Cochrane Effective Practice
and Organization Of Care (EPOC) group [55]. These cat-
egories are: patient education, promotion of self-manage-
ment, clinician education, audit and feedback, case
management, team changes, electronic patient registry,
clinician reminders, facilitated relay of clinical informa-
tion to clinicians, patient reminder systems, and continu-
ous quality improvement. Five interventions are not
included in the service program as they are either inte-
grated in other interventions of the program (e.g., the
patient reminder system is integrated with physician
reminder system) or because of complexity in the Belgian
Table 1: The MRC Framework applied for the development and evaluation of a complex intervention in diabetes care.
Phases
Phase I- Preclinical theory (Why should the intervention work?)
Content Methods Results Publications
- Collecting evidence on the 
effectiveness of multifaceted diabetes 
intervention programs – Identification 
of evidence on appropriate outcome 
indicators
- Influence of local context
Review of systematic reviews on 
diabetes care programs in 
primary care, outpatient, 
community and hospital settings 
to identify: conceptual 
backgrounds of programs, goals, 
settings, type of program, type of 
interventions, type of indicators, 
(cost) effectiveness of programs 
and interventions
Overview of best choice of interventions and 
indicators, selection of conceptual model, overview 
of major confounders, overview of strategic design 
issues, overview of barriers to high-quality diabetes 
care at the macro, meso and micro level
[37]
Phase II- Modeling (How does the intervention work?)
Content Methods Results Publications
- Understanding of the pathways by 
which the problem is caused and 
sustained
- Exploration of whether the pathways 
are amenable to change and, if so, at 
which points
- Quantification of the potential for 
improvement 
(estimates of likely effect size)
- Program development
- Stakeholder interviews to 
identify and understand barriers 
to high-quality diabetes care in 
the Belgian health care system 
and multidisciplinary team 
meetings to discuss program 
development
- Definition a multifaceted intervention/
implementation strategy and outcome-indicators and 
local adaptation of the treatment protocol
[41]
Phase III – Exploratory Trials (not performed)
Phase IV – Randomized Controlled Trial
The Diabetes Project Leuven (cluster randomized trial)
Phase V – Long Term Implementation (not performed)
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Table 2: Overview of components of the Usual Quality Improvement Program (UQIP) and Advanced Quality Improvement Program 
(AQIP).
Patient
Lack of adhere to treatment regimen and clinical inertia related to:e.g. Limited motivation or resistance to adopting lifestyles that support optimal 
disease care.
Usual Quality Improvement Program (UQIP) Advanced Quality Improvement Program 
(AQIP)
Patient education Medical assessments and education upon 
referral of the PCPs by diabetologist or DCT
Medical assessments and education upon 
referral of the PCPs by diabetologist or DCT 
(DCT)
= internist, nurse educator, dietician and 
ophthalmologist
= internist, nurse educator, flying educator, 
dietician, ophthalmologist and health 
psychologist
Promotion of self-management ---- Education of patients in practice 
(by flying educator)
---- Education at patient's home (by flying educator)
---- Counseling by health psychologist
---- Structured educational materials from DCT
---- Structured educational materials from 
community organizations
---- Group educational sessions for patients and 
family members
---- Free access to blood monitoring tools for self-
management
Professional
Lack of adherence to guidelines and clinical inertia related to:e.g. Overestimation of care actually delivered, a failure to identify 
and manage comorbid conditions, unawareness or disagreement with evidence-based goals of care and 'soft reasons' to avoid 
intensification of therapy.
Usual Quality Improvement Program (UQIP) Advanced Quality Improvement Program 
(AQIP)
Clinician education Distribution of treatment protocol Distribution of treatment protocol
Two post-graduate educational sessions Four post-graduate educational sessions 
provided by diabetologist (opinion leader):
Evidence based guidelines Evidence-based guidelines and principles of 
shared care
The use of insulin The use of insulin
Patient-centered counseling
Peer review
Standard educational materials Extended educational materials
---- Inviting PCPs during DCT meetings to discuss 
patient cases
---- Providing structured communication forms to 
PCPs by DCT
---- Distribution of shared care protocol + referral 
indication
Feedback At start and end of project: summary of clinical 
performance
Every 3 months: summaries of clinical 
performance
---- Every three months: benchmarking feedback
Reminders Clinical reminders at start and end of project Every three months: Clinical reminders
---- Every three months: Shared care reminders
Organisational
Lack of office system support and organizational aspects of care related to clinical inertia:e.g. Lack of decision support and a team approach to care.
Usual Quality Improvement Program (UQIP) Advanced Quality Improvement Program 
(AQIP)
Team changes DCT operating close to regular care Active instalment of DCT operating under 
supervision of a diabetologist from a University 
Hospital
Diabetes Program manager providing logistic 
support to PCPs
---- Introduction of shared care protocol
Active encouragement by DCT and scientific 
team of PCPs to use shared care protocol
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primary health care system (case management, audit, elec-
tronic patient registry, and facilitated relay of clinical
information to clinicians). The different implementation
strategies are derived from an overview by Grol and Wens-
ing [56], who have summarized thirteen important theo-
ries and models related to the implementation of change
to improve diabetes care. These theories/models relate to
individual professionals/patients, the social context, and
the organizational and economic context.
Level one: patient
Patient education/promotion of self-management
Both patients in the AQIP and UQIP arms can be referred
by their PCP to a DCT to receive a medical assessment by
an internist as well as to receive patient education, dietary
advice, and examination by an ophthalmologist. This core
membership of internists, nurse educators, dieticians, and
ophthalmologists reflects the basic requirements of diabe-
tes treatment: nutrition, medication, self-monitoring, self-
management, and the management of risk factors [57].
Physicians from both the AQIP and UQIP can ask
internists/diabetologists for advice on complex patient
cases, with or without patient referral. Educational serv-
ices and promotion of self-management to patients of the
AQIP and UQIP are only provided upon referral of the
physician. Nurse educators have received a post-graduate
one-year training program on diabetes nursing care. The
nurse educator applies individual patient counseling,
didactic goal-setting, and situational problem-solving as
key educational methods to patients in the AQIP, whereas
patients from the UQIP receive services approximating
regular care, i.e., individual patient counseling. Physicians
from both the AQIP and UQIP can consult dieticians for
complementary dietary advice or can refer their patients to
discuss information on meal algorithms, dietary strate-
gies, and tailoring food intake to meet the patients' life-
style, motivation, and specific needs [57]. Education on
lifestyle changes, identification of barriers to diabetes self-
management, and stress management will be provided by
a health psychologist to patients in the AQIP-program
after physician referral.
Patients in the AQIP can receive additional services,
including group educational sessions for both patients
and relatives, education at home or at the physician's
practice (provided by a traveling educator), structured and
printed educational materials from the DCT and commu-
nity organizations, and free tools for self-monitoring of
blood glucose levels.
Level two: professional
Clinician education
Interventions for clinician education include an increased
understanding of principles guiding clinical care or aware-
ness of specific recommendations for the patient popula-
tion using a treatment and shared care protocol, as well as
four post-graduate educational sessions based on the
Transtheoretical Model of Change [58]. The first session
will involve training on the use of evidence-based guide-
lines and the principles of shared care. A second and a
third session will focus on the use of insulin and patient-
centered counseling. A fourth session will be set up as a
peer review session. Educational messages are delivered,
for most part, by a locally well-known diabetologist
('opinion leader') using techniques of group academic
detailing [59]. Providing clinical leadership in secondary
care is important for PCPs working in an unstructured and
thus non-integrated health care environment.
The UQIP will incorporate only the first two sessions.
AQIP physicians can attend all four sessions and will also
receive extended educational materials. Physicians from
both groups will receive accreditation points from a
national system for their participation at the educational
sessions.
Feedback
Feedback interventions, provided by a program manager
to the physicians, will include summaries of clinical per-
formance of diabetes care delivered to individual patients
over a three-month period. AQIP physicians will receive
ongoing benchmarking feedback, whereas the UQIP will
only receive benchmarking feedback at the start and end
of the project. Feedback includes the percentage of a phy-
sician's patients who achieve target levels for glycosylated
hemoglobin, LDL, total cholesterol and triglycerides,
systolic/diastolic blood pressure, an eye and foot exami-
nation, aspirin and statin prescriptions, anti-hypertensive
medication, smoking status, and weight loss.
---- Referral arrangements
Active encouragement by DCT and scientific 
team to adhere to referral arrangements
---- Liaison activities by DCT towards in-hospital 
DCT in secondary care
---- Involvement of independent pharmacists
Continuous quality improvement Quality Assurance Team Quality Assurance Team
Table 2: Overview of components of the Usual Quality Improvement Program (UQIP) and Advanced Quality Improvement Program 
(AQIP). (Continued)
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Clinician reminders
Clinician reminders for physicians of the AQIP are com-
bined with quarterly feedback by the program manager
and reminders to make use of the DCT if treatment targets
are not met. Physicians are asked to remind their patients
about upcoming appointments. Patients are asked by the
physicians to make use of a diabetes passport in which the
appointments are noted together with important treat-
ment results. Physicians of the UQIP do not receive clini-
cian/patient reminders nor do they receive reminders on
the use of the DCT.
Level three: organisational
Team changes
Team changes are operationalized in three ways. Initially,
a DCT will be installed in two primary care facilities that
are run by PCPs. The DCTs will be intensively supervised
by a diabetologist from the academic hospital in the
project region who provides clinical leadership to the
team. All DCT members will receive a 60-hour in-house
training program on the use of a shared care protocol,
communication skills, and team dynamics. Key elements
of the interdisciplinary team include shared leadership
with common goals, shared professional identity, and col-
laborative, rather than consultative, relationships among
members [60]. Team members are expected to engage and
learn from each other and to attend scheduled meetings.
An experienced counselor and a member of the academic
project team will oversee the training program. The DCTs
operate in support of the PCPs and actively promote refer-
rals to physicians of the AQIP if treatment targets are not
met [61]. Fortnightly interdisciplinary meetings will be
organized between the members of the DCT who can
invite individual physicians from the AQIP to discuss
complex patient conditions.
Nurse educators, dieticians, and the health psychologist
will meet their colleagues from a university hospital-based
diabetes team and the supervising diabetologist on a quar-
terly basis to exchange experiences and discuss complex
patient cases. Internists will meet with the supervising dia-
betologist every other month to discuss individual patient
cases.
Structured, extensive reports will be provided by members
of the DCT to the AQIP because PCPs rank standardized,
structured correspondence very high [62,63]. Physicians
of the UQIP will only receive standard communication
forms.
Team changes will also include the active promotion of a
diabetes program manager who operates as the central
point of referral for the physicians. The program manager
will be selected based on the following criteria: strong
interpersonal communication skills, the ability to create
trust, knowledge of diabetes, and organizational capabili-
ties. The program manager will provide physicians from
the AQIP with extended (logistic) support, including phy-
sician reminders, providing feedback, liaison activities
between the DCT and physicians, organizing group edu-
cational sessions, and responding to questions on the
study or diabetes-related topics. A project website to facil-
itate this will be accessible for AQIP and UQIP physicians.
The final team change will be involvement of independ-
ent pharmacists in the study. Pharmacists are asked to
provide physicians in the AQIP program with medication
schemes of their patients upon request. As such, pharma-
cists can play a more active role in patient monitoring or
adjusting medication regimens [64-66].
Continuous quality improvement
Continuous quality improvement will be assured by an
iterative process for assessing quality problems in the
implementation of the project, developing solutions to
those problems, testing their impacts, and then reassess-
ing the need for further action. For this purpose an inter-
disciplinary quality assurance team will be established
that includes a diabetologist, four PCPs, two nurses,
internists, dieticians, and pharmacists. The quality assur-
ance team will be asked to monitor the implementation of
the project, as well as evaluate outcome indicators of the
project. Meetings will be organized on a regular basis with
individual members of the quality assurance team.
Sample size
The project funding agency requires a sample size of at
least one-third of the potential PCPs (n = 379), which
would capture roughly 2,500 patients with type 2 diabetes
mellitus. This sample size allows 80% power (type II
error: 0.20) to detect a 20% relative difference between
the intervention arms in the proportion of patients
achieving a 10% improvement in any one of the follow-
ing: blood pressure, total cholesterol, or HbA1c (type I
error: 0.05; assumed intracluster coefficient 0.6; [67] for
calculation methods).
Randomization and allocation concealment
After recruitment, a researcher not involved in the study
and blind to the identity of the practices will perform a
randomization (by computer-generated numbers) strati-
fied by practice size (solo/duo/group practice) and the
presence or absence of an electronic medical recording
system. To minimize the possibility of selection bias, all
patients within a cluster will be included. Blinding will be
ensured for the participating patients, but is not possible
at the physician level.
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Data collection
These practices have no pre-existing registers of diabetic
patients. Patients with type 2 diabetes mellitus will be
identified using physician memory, searching computer-
ized records, and laboratory lists of patients with
increased glycemia or registered glycosylated hemoglobin.
Baseline data will be collected over a seven-month period.
PCPs will be asked to perform a complete examination
and blood analysis at the patient's first visit and to com-
plete a paper form. Identified patients without a visit dur-
ing the first three months of the project will be invited to
participate. The completeness of data capture will be dou-
ble-checked by a data monitor. Final data will be collected
over a seven-month period, with call-backs for non-com-
pliant patients. Patient data sheets include socio-demo-
graphic and biomedical data. PCPs will need to indicate
whether diabetes is treated by the PCP or in a diabetes
clinic.
Primary and secondary endpoints
The primary endpoints of the study are the proportion of
patients reaching ADA targets for three clinical outcomes:
HbA1c < 7%; SBD ≤ 130 mmHg; and LDL-C < 100 mg/dl.
Secondary endpoints are the mean improvements in indi-
vidual values of 12 validated parameters: HbA1c, LDL-C,
HDL-C, Total Cholesterol, SBP, DBP, weight, physical
exercise, healthy diet, smoking status, and statin and anti-
platelet therapy.
Statistical analysis
Statistical analyses will be performed using an intent-to-
treat approach with a multilevel model. Linear and gener-
alized linear mixed models will be used to account for the
clustered nature of the data, i.e., patients clustered within
PCPs, and repeated assessments clustered within patients.
Such models measure how outcomes change over time
within patients and whether these changes depend on
patient and/or PCP's characteristics, such as the interven-
tion program or DCT use (see hypothesis two). DCT use is
defined as having at least one consultation with a member
of the team besides the health psychologist and the
traveling educator, which are only available for AQIP
patients.
We will use generalized estimating equations (GEE), an
extension of the quasi-likelihood approach, to test for dif-
ferences in the evolution of the primary and secondary
endpoints for all patients and within the intervention
arms. For binary variables, we use the exponential inverse
transformation to obtain the 95% confidence interval for
the odds ratio.
Subgroup analyses (see hypothesis one) can distinguish
intervention effects using different cut-off values. For
HbA1C, three subgroups are defined: patients with HbA1c
< 7%; HbA1c ≥ 7% and < 8%; and HbA1c ≥ 8%. For SBP,
four subgroups are defined: patients with SBP ≤ 130
mmHg; SBP > 130 mmHg and ≤ 140 mmHg; SBP > 140
mmHg and ≤ 160 mmHg; and SBP > 160 mmHg. For
LDL-C, four subgroups are defined: patients with LDL-C <
100 mg/dl; LDL-C ≥ 100 mg/dl and < 115 mg/dl; LDL-C ≥
115 mg/dl and < 130 mg/dl; and LDL-C > 130 mg/dl.
Linear mixed models with subject-specific intercepts and
slopes are used to test whether subject-specific evolutions
are related to initial parameters. HbA1c will be trans-
formed logarithmically to meet the parametric assump-
tions of the statistical models. All analyses will be
performed using SAS, version 9.
Discussion
Trials of complex interventions inform the drive to pro-
vide the most cost-effective health care [7]. RCTs are rec-
ognized as the 'gold standard' methodology in
quantitative research. Health care interventions are, how-
ever, often complex and are always implemented in com-
plex health care settings [68-71]. Complex interventions
often have particular characteristics that reduce chances of
success in a RCT, including the incorporation of multiple
components, targeting multiple outcomes, being difficult
to implement or evaluate, or aiming to achieve outcomes
that are notoriously difficult to influence [72]. In this con-
text, the complexity of an intervention can present a sub-
stantial barrier to its adoption [73]. Complex
interventions therefore have greater scope for variation in
their delivery and are more vulnerable to one or more
components not being implemented correctly [74].
Although we have not performed a pilot trial to assist in
data interpretation or clarify process and outcome results,
our stakeholder analysis informed our understanding of
existing barriers to high-quality diabetes care and allowed
us to incorporate innovative change interventions, such as
interdisciplinary teams operating on the primary/spe-
cialty care interface and educational strategies that target
changes in professional practice and improvements in
patient empowerment [75]. These hypotheses will be
tested using a large group of physicians and patients over
an 18-month period. Most quality improvement pro-
grams include smaller target groups and shorter interven-
tion periods of six months, which may not be long
enough to completely remove the Hawthorne effect. Our
study also targets the primary/specialty care interface, an
important attribute of high-quality diabetes care [76]. In
particular, the clinical leadership and coaching provided
by a diabetologist to both the PCPs and the DCT is of par-
ticular importance in fragmented systems of care, such as
in Belgium. We also explicitly focus on multiple cardio-
vascular risk factors as the primary outcomes, whereas
other studies have not [77]. Finally, we incorporate all six
Implementation Science 2008, 3:42 http://www.implementationscience.com/content/3/1/42
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dimensions of the CCM,, and are only the fourth study in
diabetes care to do so [9,78,79]. The use of all six dimen-
sions of the CCM permits evaluation of how CCM com-
ponents are associated with improved outcomes to further
refine the model. We therefore explicitly describe how the
implementation strategies relate to every dimension of
the CCM. Implementation strategies in complex interven-
tions are rarely described [80], even in large-scale imple-
mentation studies, which limits the understanding of why
an intervention is or is not locally successful [81].
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